Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (KYTX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 23 transactions totaling $47.7M, demonstrating a bullish sentiment with $47.1M in net insider flow. The most recent transaction on Feb 24, 2026 involved a transaction of 42,945 shares valued at $0.
KYTX Insider Activity Summary
Who Is Buying KYTX Stock?
No significant insider buying has been recorded for KYTX in the recent period.
Who Is Selling KYTX Stock?
No significant insider selling has been recorded for KYTX in the recent period.
Is Kyverna Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KYTX is bullish with an Insider Alignment Score of 99/100 and a net flow of $47.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
KYTX Frequently Asked Questions
Understanding KYTX Insider Activity
Insider trading at Kyverna Therapeutics, Inc. (KYTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading KYTX stock, having executed 23 transactions in the past 90 days. The most active insider is Sciences, Inc. Gilead (Executive), who has made 2 transactions totaling $20.0M.
Related Tools
Track Kyverna Therapeutics, Inc. Insider Activity
Get notified when executives and directors at KYTX file new Form 4 transactions